DavidChismMDMS

PubMed

• Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma.
  Daniel P Petrylak, Bernhard J Eigl, Saby George, Elisabeth I Heath, Sebastien J Hotte
  Clinical Cancer Research. 2024-01-05
• 37 citations
  Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer.
  Julie Fu, Sonya A Reid, Benjamin French, Cassandra Hennessy, Clara Hwang
  JAMA Network Open. 2022-03-01
• 5 citations
  Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States.
  Jessica E Hawley, Tianyi Sun, David D Chism, Narjust Duma, Julie C Fu
  JAMA Network Open. 2022-01-04

Journal Articles

• Metachronous Bilateral Testicular Leydig-Like Tumors Leading to the Diagnosis of Congenital Adrenal Hyperplasia (Adreno-Genital Syndrome)  
  Vukina, J, Chism DD, Sharpless J, Raynor M, Milowsky, MI and Funkhouser W, Case Rep Pathol, 1/1/2015
• Mechanisms of acquired resistance to androgen receptor targeting drugs in castration resistant prostate cancer  
  Chism D, De Silva D, Whang YE, Expert Review of Anticancer Therapy, 1/13/2014
• Seeing the forest for the trees: kidney oncogenomes in relation to therapeutic outcomes  
  Chism, D and Rathmell, WK, Clin Cancer Res, 1/1/2014
• Neoadjuvant Paradigm for Bladder Cancer: An Ideal Model for Accelerated Drug Development  
  Chism, D, Woods, M, Milowsky, MI, The Oncologist, 1/1/2013
• Targeting Survivin expression induces cell proliferation defect and subsequent cell death involving mitochondrial pathway in myeloid leukemic cells.  
  Carter BZ, Wang RY, Schober WD, Milella M, Chism DD, Andreeff M., Cell Cycle, 9/2003
• IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK.  
  Moore PE, Church TL, Chism DD, Panettieri RA, Shore SA, Am J Physiol Lung Cell Mol Physiology, 4/2002
• Join now to see all

Books/Book Chapters

• Advances in Bladder Cancer Management 
  Chapter: Chemotherapy for Metastatic Bladder Cancer 
  Chism, D, Apolo, A, Milowsky, MEditors: Xylinas E, Shariat SF.Future Science, London, UK2015
• Renal Cell Carcinoma 
  Chapter: Prognostic and Predictive Biomarkers in Renal Cell Carcinoma 
  Chism, D, Rathmell, WKEditors: Nizar Tannir.Oxford American Oncology Library, New York, NY2014

Abstracts/Posters

• LCCC 1406: A Phase II Trial of Palbociclib (PD-332991) in Patients with Metastatic Urothelial Cancer (UC) after Failure of First-Line Chemotherapy.
  Rose, TL, Alva, AS, Chism, DD, Deal, AM, Kim, WY, and Milowsky, MI, ASCO, 1/1/2016
• Evaluation of basal and luminal subtypes of urothelial carcinoma in African American and non-African American patients.
  Kardos, J, Melquist, J, Chism, D, Choi, W, Cockerill, K, Paluri, R, Moses, K, Sonpavde, G, McConkey, D, Kim, W, Dinney, C, Milowsky, M, J Clin Oncol, 1/1/2015
• BASE47 gene set predictor as an identifier of "basal-like" subtype of urothelial carcinoma of the bladder in African Americans.
  Chism DD, Damrauer,JS, Miller A, Milowsky MI, Kim WY, J Clin Oncol, 1/1/2014
• African-Americans and Bladder cancer, Defining Intrinsic biology and Outcome.
  Chism DD, Damrauer,JS, Gallagher SA, Milowsky MI, Kim WY, J Clin Oncol, 1/1/2013
• Join now to see all